Bone metastasis is a common complication of cancer, where cancer cells spread to the bones from other parts of the body. It is most commonly seen in cancers such as breast, prostate, lung, and kidney. Symptoms of bone metastasis include pain, fractures, and decreased mobility. Treatment options include radiation therapy, chemotherapy, and targeted therapies. Surgery may also be used to remove the cancer cells from the bone. The bone metastasis market is a subset of the oncology market, and is expected to grow due to the increasing prevalence of cancer and the development of new treatments. The market is driven by factors such as the increasing geriatric population, rising healthcare expenditure, and the availability of advanced treatments. Some companies in the bone metastasis market include Novartis, Amgen, Merck, Pfizer, and Eli Lilly. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
